help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2005-1410
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
147/9/3995    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vuguin, P. M.
Right arrow Articles by Teitelman, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vuguin, P. M.
Right arrow Articles by Teitelman, G.
Endocrinology Vol. 147, No. 9 3995-4006
Copyright © 2006 by The Endocrine Society

Ablation of the Glucagon Receptor Gene Increases Fetal Lethality and Produces Alterations in Islet Development and Maturation

Patricia M. Vuguin, Mamdouh H. Kedees, Lingguang Cui, Yelena Guz, Richard W. Gelling, Morris Nejathaim, Maureen J. Charron and Gladys Teitelman

Departments of Pediatrics (P.M.V.) and Biochemistry (P.M.V., L.C., R.W.G., M.J.C.), Albert Einstein College of Medicine, Bronx, New York 10461; Department of Anatomy and Cell Biology (M.H.K., Y.G., M.N., G.T.), State University of New York-Downstate Medical Center, Brooklyn, New York 11203; and Metabolex Inc. (R.W.G.), Hayward, California 94545

Address all correspondence and requests for reprints to: Patricia Vuguin, Division of Pediatric Endocrinology, Children’s Hospital at Montefiore Medical Center, 111 East 210th Street, Bronx, New York 10476. E-mail: vuguin{at}aecom.yu.edu.

Although glucagon (GLU) plays a pivotal role in glucose homeostasis, its role in the regulation of fetal growth and maturation is poorly understood. These issues were examined in a line of mice with a global deletion of the GLU receptor (Gcgr–/–), which are characterized by lower blood glucose levels and by {alpha}- and {delta}-cell hyperplasia in adults. Ablation of Gcgr was deleterious to fetal survival; it delayed ß-cell differentiation and perturbed the proportion of ß- to {alpha}-cells in embryonic islets. In adults, the mutation inhibited the progression of {alpha}-cells to maturity, affected the expression of several ß-cell-specific genes, and resulted in an augmentation of the {alpha}-, ß-, and {delta}-cell mass. This increase was due to an augmentation in both islet number and in the rate of proliferation of cells expressing GLU or insulin. These findings suggest that GLU participates in a feedback loop that regulates the proportion of the different endocrine cell types in islets, the number of islets per pancreas, and development of the mature {alpha}-cell phenotype.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
J. Gromada, I. Franklin, and C. B. Wollheim
{alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Endocr. Rev., February 1, 2007; 28(1): 84 - 116.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. K. Gittes
Islet Development: When Glucagon's Gone.
Endocrinology, September 1, 2006; 147(9): 3993 - 3994.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society